We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
27 hedge funds and large institutions have $11.1M invested in Regulus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
47,700% more call options, than puts
Call options by funds: $956K | Put options by funds: $2K
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
13% more funds holding
Funds holding: 24 → 27 (+3)
7.38% less ownership
Funds ownership: 55.58% → 48.2% (-7.4%)
20% less capital invested
Capital invested by funds: $13.8M → $11.1M (-$2.72M)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
7
Closed
1
Calls
$956K
Puts
$2K
Net Calls
+$954K
Net Calls Change
-$184K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$66.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.27K |
| 4 |
Renaissance Technologies
New York
|
+$3.77K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$473 |
Top Sellers
| 1 |
HF
HRT Financial
New York
|
-$38K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$25.2K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$11.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.1K |
| 5 |
BlackRock
New York
|
-$1.45K |
